6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid has been researched along with Multiple Sclerosis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Besler, HT; Comoğlu, S | 1 |
1 other study(ies) available for 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid and Multiple Sclerosis
Article | Year |
---|---|
Lipoprotein oxidation, plasma total antioxidant capacity and homocysteine level in patients with multiple sclerosis.
Topics: Adult; Antioxidants; Autoantibodies; Chromans; Female; Folic Acid; Homocysteine; Humans; Lipid Peroxidation; Lipoproteins; Lipoproteins, LDL; Male; Multiple Sclerosis; Oxidation-Reduction; Oxidative Stress; Vitamin B 12; Vitamin E | 2003 |